{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"25"},{"groupId":"OG002","value":"31"},{"groupId":"OG003","value":"22"},{"groupId":"OG004","value":"15"}],"units":"Participants"}],"title":"Eosinophilia, Increase to Grades 1 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"25"},{"groupId":"OG002","value":"31"},{"groupId":"OG003","value":"22"},{"groupId":"OG004","value":"15"}],"units":"Participants"}],"title":"Eosinophilia, Increase to Grades 2 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"25"},{"groupId":"OG002","value":"31"},{"groupId":"OG003","value":"22"},{"groupId":"OG004","value":"15"}],"units":"Participants"}],"title":"Eosinophilia, Increase to Grades 3 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"15"},{"groupId":"OG002","value":"20"},{"groupId":"OG003","value":"15"},{"groupId":"OG004","value":"6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"38"},{"groupId":"OG003","value":"40"},{"groupId":"OG004","value":"16"}],"units":"Participants"}],"title":"Anemia, Increase to Grades 1 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"16"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"17"},{"groupId":"OG003","value":"14"},{"groupId":"OG004","value":"5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"38"},{"groupId":"OG003","value":"40"},{"groupId":"OG004","value":"16"}],"units":"Participants"}],"title":"Anemia, Increase to Grades 2 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"9"},{"groupId":"OG002","value":"11"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"38"},{"groupId":"OG003","value":"40"},{"groupId":"OG004","value":"16"}],"units":"Participants"}],"title":"Anemia, Increase to Grades 3 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"38"},{"groupId":"OG003","value":"40"},{"groupId":"OG004","value":"16"}],"units":"Participants"}],"title":"Hemoglobin increased, Increase to Grades 1 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"38"},{"groupId":"OG003","value":"40"},{"groupId":"OG004","value":"16"}],"units":"Participants"}],"title":"Hemoglobin increased, Increase to Grades 2 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"38"},{"groupId":"OG003","value":"40"},{"groupId":"OG004","value":"16"}],"units":"Participants"}],"title":"Hemoglobin increased, Increase to Grades 3 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"37"},{"groupId":"OG003","value":"40"},{"groupId":"OG004","value":"16"}],"units":"Participants"}],"title":"Leukocytosis, Increase to Grades 1 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"37"},{"groupId":"OG003","value":"40"},{"groupId":"OG004","value":"16"}],"units":"Participants"}],"title":"Leukocytosis, Increase to Grades 2 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"37"},{"groupId":"OG003","value":"40"},{"groupId":"OG004","value":"16"}],"units":"Participants"}],"title":"Leukocytosis, Increase to Grades 3 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"22"},{"groupId":"OG001","value":"17"},{"groupId":"OG002","value":"18"},{"groupId":"OG003","value":"19"},{"groupId":"OG004","value":"9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"37"},{"groupId":"OG003","value":"40"},{"groupId":"OG004","value":"16"}],"units":"Participants"}],"title":"White blood cell decreased, Increase to Grades 1 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"17"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"13"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"37"},{"groupId":"OG003","value":"40"},{"groupId":"OG004","value":"16"}],"units":"Participants"}],"title":"White blood cell decreased, Increase to Grades 2 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"5"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"37"},{"groupId":"OG003","value":"40"},{"groupId":"OG004","value":"16"}],"units":"Participants"}],"title":"White blood cell decreased, Increase to Grades 3 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"18"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"15"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"6"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"28"},{"groupId":"OG004","value":"15"}],"units":"Participants"}],"title":"Lymphocyte count decreased, Increase to Grades 1 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"11"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"5"},{"groupId":"OG004","value":"3"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"28"},{"groupId":"OG004","value":"15"}],"units":"Participants"}],"title":"Lymphocyte count decreased, Increase to Grades 2 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"4"},{"groupId":"OG004","value":"1"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"28"},{"groupId":"OG004","value":"15"}],"units":"Participants"}],"title":"Lymphocyte count decreased, Increase to Grades 3 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"4"},{"groupId":"OG004","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"28"},{"groupId":"OG004","value":"15"}],"units":"Participants"}],"title":"Lymphocyte count increased, Increase to Grades 1 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"4"},{"groupId":"OG004","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"28"},{"groupId":"OG004","value":"15"}],"units":"Participants"}],"title":"Lymphocyte count increased, Increase to Grades 2 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"0"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"33"},{"groupId":"OG001","value":"28"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"28"},{"groupId":"OG004","value":"15"}],"units":"Participants"}],"title":"Lymphocyte count increased, Increase to Grades 3 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"12"},{"groupId":"OG002","value":"12"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"35"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"31"},{"groupId":"OG004","value":"15"}],"units":"Participants"}],"title":"Neutrophil count decreased, Increase to Grades 1 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"10"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"7"},{"groupId":"OG004","value":"4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"35"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"31"},{"groupId":"OG004","value":"15"}],"units":"Participants"}],"title":"Neutrophil count decreased, Increase to Grades 2 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"3"},{"groupId":"OG004","value":"4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"35"},{"groupId":"OG001","value":"29"},{"groupId":"OG002","value":"32"},{"groupId":"OG003","value":"31"},{"groupId":"OG004","value":"15"}],"units":"Participants"}],"title":"Neutrophil count decreased, Increase to Grades 3 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"30"},{"groupId":"OG002","value":"23"},{"groupId":"OG003","value":"21"},{"groupId":"OG004","value":"7"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"37"},{"groupId":"OG003","value":"40"},{"groupId":"OG004","value":"16"}],"units":"Participants"}],"title":"Platelet count decreased, Increase to Grades 1 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"15"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"12"},{"groupId":"OG003","value":"13"},{"groupId":"OG004","value":"5"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"37"},{"groupId":"OG003","value":"40"},{"groupId":"OG004","value":"16"}],"units":"Participants"}],"title":"Platelet count decreased, Increase to Grades 2 to 4"},{"categories":[{"measurements":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"13"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"4"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"37"},{"groupId":"OG003","value":"40"},{"groupId":"OG004","value":"16"}],"units":"Participants"}],"title":"Platelet count decreased, Increase to Grades 3 to 4"}],"denoms":[{"counts":[{"groupId":"OG000","value":"38"},{"groupId":"OG001","value":"39"},{"groupId":"OG002","value":"38"},{"groupId":"OG003","value":"40"},{"groupId":"OG004","value":"16"}],"units":"Participants"}],"description":"Blood samples were collected for the analysis of hematology parameters. The parameters were graded according to CTCAE grades. Grade 1: Mild; Grade 2: Moderate; Grade 3: Severe or medically significant but not immediately life-threatening; Grade 4: Life-threatening consequences; Grade 5: Death related to AE. Higher grades indicate greater severity and an increase in CTCAE grade was defined relative to the Baseline grade. Any worst-case post baseline increases in grade 1/2/3 to a grade of 4 are presented.","groups":[{"description":"Participants with Relapsed or Refractory Multiple Myeloma (RRMM) received belantamab mafodotin as 2.5 milligram (mg)/kilogram (kg) dose on Day 1 of every 3 weeks (Q3W) as a 30-60 minute intravenous (IV) infusion until confirmed disease progression, unacceptable toxicity or death.","id":"OG000","title":"Arm A: Belantamab Mafodotin 2.5 Milligram (mg)/Kilogram (kg) Every 3 Weeks (Q3W)"},{"description":"Participants with RRMM received belantamab mafodotin as 1.9 mg/kg dose on Day 1 of Q3W as a 30-60 minute IV infusion until confirmed disease progression, unacceptable toxicity or death.","id":"OG001","title":"Arm B: Belantamab Mafodotin 1.9 mg/kg Q3W"},{"description":"Participants with RRMM received belantamab mafodotin as 2.5 mg/kg dose on Day 1 of every 6 weeks (Q6W) as a 30-60 minute IV infusion until confirmed disease progression, unacceptable toxicity or death.","id":"OG002","title":"Arm C: Belantamab Mafodotin 2.5 mg/kg Every 6 Weeks (Q6W)"},{"description":"Participants with RRMM received belantamab mafodotin as 1.9 mg/kg dose on Day 1 of Q6W as a 30-60 minute IV infusion until confirmed disease progression, unacceptable toxicity or death.","id":"OG003","title":"Arm D: Belantamab Mafodotin 1.9 mg/kg Q6W"},{"description":"Participants with RRMM received belantamab mafodotin as 1.9 mg/kg dose on Day 1 of Q6W as a 30-60 minute IV infusion until confirmed disease progression, unacceptable toxicity or death. For this arm, dose modification decisions were determined by the results of the Ocular Surface Disease Index (OSDI) questionnaire or VA assessments using Snellen chart. The OSDI scale assesses the severity of eye symptoms and their impact and Snellen chart is for the assessment of visual acuity.","id":"OG004","title":"Arm E: Belantamab Mafodotin 1.9 mg/kg Q6W (Based on OSDI + Visual Acuity [VA] Assessment)"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Safety Population. Only those participants with data available for specified categories have been analyzed. Participants were counted more than once within some categories, so the percentages may not add to 100 percent (%).","reportingStatus":"POSTED","timeFrame":"Up to 152 weeks","title":"Number of Participants With Worst-Case Hematology Results by Maximum Grade Increase Post-Baseline Relative to Baseline","type":"SECONDARY","unitOfMeasure":"Participants"}